Australia
· Delayed Price · Currency is AUD Imricor Medical Systems Statistics
Total Valuation
Imricor Medical Systems has a market cap or net worth of AUD 276.93 million. The enterprise value is 288.80 million.
| Market Cap | 276.93M |
| Enterprise Value | 288.80M |
Important Dates
The next estimated earnings date is Monday, February 24, 2025.
| Earnings Date | Feb 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Imricor Medical Systems has 270.18 million shares outstanding. The number of shares has increased by 17.63% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 270.18M |
| Shares Change (YoY) | +17.63% |
| Shares Change (QoQ) | +17.88% |
| Owned by Insiders (%) | 8.65% |
| Owned by Institutions (%) | 12.38% |
| Float | 222.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 146.19 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.51 |
| EV / Sales | 233.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.99 |
Financial Position
The company has a current ratio of 1.46
| Current Ratio | 1.46 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.64 |
| Interest Coverage | -592.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -124.67% |
| Return on Capital (ROIC) | -242.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +92.45% in the last 52 weeks. The beta is 0.27, so Imricor Medical Systems's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +92.45% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 50.77 |
| Average Volume (20 Days) | 421,604 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Imricor Medical Systems had revenue of AUD 1.24 million and -30.37 million in losses. Loss per share was -0.17.
| Revenue | 1.24M |
| Gross Profit | -1.37M |
| Operating Income | -23.67M |
| Pretax Income | -30.37M |
| Net Income | -30.37M |
| EBITDA | -22.59M |
| EBIT | -23.67M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 2.25 million in cash and 14.12 million in debt, giving a net cash position of -11.87 million or -0.04 per share.
| Cash & Cash Equivalents | 2.25M |
| Total Debt | 14.12M |
| Net Cash | -11.87M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -9.65M |
| Book Value Per Share | -0.05 |
| Working Capital | 1.93M |
Cash Flow
In the last 12 months, operating cash flow was -22.17 million and capital expenditures -62,579, giving a free cash flow of -22.23 million.
| Operating Cash Flow | -22.17M |
| Capital Expenditures | -62,579 |
| Free Cash Flow | -22.23M |
| FCF Per Share | -0.08 |
Margins
| Gross Margin | -110.81% |
| Operating Margin | -1,916.15% |
| Pretax Margin | -2,458.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Imricor Medical Systems does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.63% |
| Shareholder Yield | -17.63% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Imricor Medical Systems has an Altman Z-Score of -25.6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.6 |
| Piotroski F-Score | n/a |